Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome.

Rim CL, Gitlin MJ.

J Clin Psychopharmacol. 2010 Aug;30(4):470-1. doi: 10.1097/JCP.0b013e3181e63033. No abstract available.

PMID:
20631570
2.

[Life-threatening serotonin syndrome following a single dose of a serotonin reuptake inhibitor during maintenance therapy with a monoamine oxidase inhibitor].

G├╝zelcan Y, Kleinpenning AS.

Ned Tijdschr Geneeskd. 2006 Aug 5;150(31):1748; author reply 1748-9. Dutch. No abstract available.

PMID:
16927475
3.

Ziprasidone and hypomania.

Duggal HS, Singh I.

CNS Spectr. 2005 Aug;10(8):606; author reply 606. No abstract available.

PMID:
16173129
4.

Acute urinary retention associated with selective serotonin reuptake inhibitors and ziprasidone.

Chung AK, Chua SE.

J Clin Psychopharmacol. 2007 Oct;27(5):517-9. No abstract available.

PMID:
17873690
5.

Serotonin syndrome resulting from drug interactions.

Chan BS, Graudins A, Whyte IM, Dawson AH, Braitberg G, Duggin GG.

Med J Aust. 1998 Nov 16;169(10):523-5.

PMID:
9861909
6.

Primary add-on of ziprasidone in sertraline treatment of posttraumatic stress disorder: lessons from a stopped trial?

Kellner M, Muhtz C, Wiedemann K.

J Clin Psychopharmacol. 2010 Aug;30(4):471-3. doi: 10.1097/JCP.0b013e3181e79600. No abstract available.

PMID:
20631571
7.

Not all monoamine oxidase inhibitors are created equal.

Stewart JT.

J Am Geriatr Soc. 2007 Nov;55(11):1890. No abstract available.

PMID:
17979910
8.

[Irreversible, non-selective monoamine oxidase inhibitors].

Castberg I, Spigset O.

Tidsskr Nor Laegeforen. 2009 Apr 16;129(8):746-8. doi: 10.4045/tidsskr.09.34296. Norwegian.

9.

Serotonin syndrome precipitated by the monoamine oxidase inhibitor linezolid.

Packer S, Berman SA.

Am J Psychiatry. 2007 Feb;164(2):346-7. No abstract available.

PMID:
17267801
10.

[Ziprasidone and dementia].

Aakhus E.

Tidsskr Nor Laegeforen. 2004 Aug 26;124(16):2155-6; author reply 2155-6. Norwegian. No abstract available.

11.

Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression.

Goforth HW, Carroll BT.

J Clin Psychopharmacol. 2007 Apr;27(2):216-7. No abstract available.

PMID:
17414252
12.

Immediate switching from moclobemide to duloxetine may induce serotonin syndrome.

Jimenez-Genchi A.

J Clin Psychiatry. 2006 Nov;67(11):1821-2. No abstract available.

PMID:
17196070
13.

Disseminated intravascular coagulation and acute myoglobinuric renal failure: a consequence of the serotonergic syndrome.

Miller F, Friedman R, Tanenbaum J, Griffin A.

J Clin Psychopharmacol. 1991 Aug;11(4):277-9. No abstract available.

PMID:
1918432
14.

Serotonin syndrome caused by ziprasidone alone.

Lin PY, Hong CJ, Tsai SJ.

Psychiatry Clin Neurosci. 2010 Jun;64(3):338-9. doi: 10.1111/j.1440-1819.2010.02086.x. No abstract available.

15.

Introduction. Ziprasidone in schizophrenia: from acute treatment to long-term management.

Kane JM.

J Clin Psychiatry. 2003;64 Suppl 19:3-5. No abstract available.

16.

Fatal interaction between tranylcypromine and imipramine.

Otte W, Birkenhager TK, van den Broek WW.

Eur Psychiatry. 2003 Aug;18(5):264-5.

PMID:
12927331
17.

Experience with ziprasidone.

Patel NC, Sierk P, Dorson PG, Crismon L.

J Am Acad Child Adolesc Psychiatry. 2002 May;41(5):495. No abstract available.

PMID:
12014778
18.

Switching monoamine oxidase inhibitors.

True BL, Alexander B, Carter B.

Drug Intell Clin Pharm. 1985 Nov;19(11):825-7.

PMID:
4064915
19.

Ziprasidone and migraine headache.

Boeker T.

Am J Psychiatry. 2002 Aug;159(8):1435-6. No abstract available.

PMID:
12153843
20.

Electroconvulsive therapy and monoamine oxidase inhibitors.

Ribeiro RB, Rosa MA, Rigonatti SP.

Rev Bras Psiquiatr. 2008 Dec;30(4):406-7. No abstract available.

Supplemental Content

Support Center